Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Sonic Healthcare Limited ( (AU:SHL) ).
Sonic Healthcare Limited has announced a change in the director’s interest, specifically involving Mark Raymond Compton. On October 2, 2025, Compton acquired 1,500 fully paid ordinary shares in Sonic Healthcare Limited through an on-market purchase, increasing his indirect holdings in the company. This change reflects a strategic move by the director to increase his stake in the company, potentially signaling confidence in Sonic Healthcare’s future performance and stability.
The most recent analyst rating on (AU:SHL) stock is a Hold with a A$24.00 price target. To see the full list of analyst forecasts on Sonic Healthcare Limited stock, see the AU:SHL Stock Forecast page.
More about Sonic Healthcare Limited
Sonic Healthcare Limited operates in the healthcare industry, primarily focusing on providing laboratory and diagnostic services. The company is a significant player in the medical diagnostics market, offering a range of services that cater to both local and international markets.
Average Trading Volume: 1,429,871
Technical Sentiment Signal: Sell
Current Market Cap: A$10.54B
For an in-depth examination of SHL stock, go to TipRanks’ Overview page.